Doré, Caroline J

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2013) · Annals of Internal Medicine

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 7,363

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials

Gamble, C., Krishan, A., Stocken, D., Lewis, S., Juszczak, E., Doré, C., Williamson, P. R., Altman, D. G., Montgomery, A., Lim, P., et al. (2017) · JAMA

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 536

Randomisation and baseline comparisons in clinical trials

Altman, D. G., & Doré, C. J. (1990) · The Lancet

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 508

The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies

Kahan, B. C., Jairath, V., Doré, C. J., & Morris, T. P. (2014) · Trials

Statistical Methods in Clinical TrialsAdvanced Causal Inference Techniques

Cited by 497

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

Cohen, H., Hunt, B. J., Efthymiou, M., Arachchillage, D. R. J., Mackie, I. J., Clawson, S., Sylvestre, Y., Machin, S. J., Bertolaccini, M. L., Ruiz-Castellano, M., et al. (2016) · The Lancet Haematology

Systemic Lupus Erythematosus ResearchVenous Thromboembolism Diagnosis and Management

Cited by 410

Early Intervention for the Management of Acute Low Back Pain: A Single-Blind Randomized Controlled Trial of Biopsychosocial Education, Manual Therapy, and Exercise

Wand, B. M., Bird, C., McAuley, J. H., Doré, C. J., MacDowell, M., & De Souza, L. H. (2004) · Spine

Musculoskeletal pain and rehabilitationSpine and Intervertebral Disc Pathology

Cited by 148

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials

Kahan, B. C., Cro, S., Doré, C. J., Bratton, D. J., Rehal, S., Maskell, N. A., Rahman, N., & Jairath, V. (2014) · Trials

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 123

Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study

Backos, M., Rai, R., Thomas, E., Murphy, M., Doré, C., & Regan, L. (1999) · Human Reproduction

Systemic Lupus Erythematosus ResearchBone health and osteoporosis research

Cited by 84

The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes

Kousta, E., Efstathiadou, Z., Lawrence, N. J., Jeffs, J. A. R., Godsland, I. F., Barrett, S. C., Doré, C. J., Penny, A., Anyaoku, V., Millauer, B. A., et al. (2006) · Diabetologia

Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 74